CRELUX GmbH
Biotechnology
-
Short facts
-
- Research & Development
- Service Provider
- Year founded 2005
- 26 Employees (site)
- Turnover: <5m EUR
Products/services: CRELUX is a global leader for structure based drug discovery solutions. Working for pharma, biotech and research organizations our products and services are highly individualized for our customers - 3 D structural analysis of target/compound complexes - Compound screening - Fragment screening - Recombinant proteins for assays, diagonstics and crystallization
Basic data
Company
CRELUX GmbH
Street
Am Klopferspitz 19a
PC / City
82152 Planegg
County
Upper Bavaria
Phone
+49 89 700760-201
Fax
+49 89 700760-222
Homepage
Language skills
English, French, German, Spanish
Profile/competences
Core competencies
CRELUX provides fast and affordable access to co-crystal structures of your compounds in complex with their protein targets; Crystallization conditions of numerous relevant therapeutic targets have been established at CRELUX; Co-crystal structures of these targets in complex with your compounds of interest will be delivered at a fixed price with a typical turn around time of six to eight weeks; We do everything to protect your most important asset: compound IP.
State-of the art proein production set-up to produce also challenging proteins in highest quality
Key sectors / sub-sectors
- Biotechnology: Analytics and separation technology
Certifications
not available
Sales markets - target industries
Pharmaindustrie Biotechnologie Chemische Industrie
Sales markets - target countries
Belgium, Canada, Denmark, France, Germany, India, Italy, Japan, Spain, Sweden, Switzerland, United Kingdom, United States
Cooperation offers
not available